Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 23 of Nkarta, Inc.'s SEC filings and found 1 warrant series, 1 ATM program and 2 shelf registrations on file for NKTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 6, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
OTLKOutlook Therapeutics, Inc.
ARMPArmata Pharmaceuticals, Inc.
VYGRVoyager Therapeutics, Inc.
AVXLAnavex Life Sciences Corp.
HURATuHURA Biosciences, Inc.
EQEquillium, Inc.
PYPDPolyPid Ltd. Ordinary Shares
LENZLENZ Therapeutics, Inc.
KZIAKazia Therapeutics Limited American Depositary Shares
NMRANeumora Therapeutics, Inc. Common Stock
NERVMinerva Neurosciences, Inc.
ANIXAnixa Biosciences, Inc.
CDXSCodexis, Inc.
PMVPPMV Pharmaceuticals, Inc.
HUMAHumacyte, Inc.